Advertisement
Canada markets closed
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7248
    -0.0015 (-0.21%)
     
  • CRUDE OIL

    85.30
    +2.57 (+3.11%)
     
  • Bitcoin CAD

    83,339.05
    -1,624.44 (-1.91%)
     
  • CMC Crypto 200

    1,263.08
    +377.54 (+40.43%)
     
  • GOLD FUTURES

    2,427.50
    +29.50 (+1.23%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • NASDAQ futures

    17,227.25
    -320.00 (-1.82%)
     
  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • NIKKEI 225

    36,948.47
    -1,131.23 (-2.97%)
     
  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

Biotechs Find Strength In Numbers In Treating Multiple Sclerosis

Biotechs Find Strength In Numbers In Treating Multiple Sclerosis

Roche, Celgene and Novartis could change the multiple sclerosis landscape, a sector now dominated by Biogen.